Innovative ovarian cancer research made possible through donor funding

In 2023, it is estimated that over 1,800 Australians were diagnosed with ovarian cancer. For these people, treatment can involve invasive surgery and chemotherapy, leaving them physically and emotionally vulnerable, even after they have finished treatment. 

​St John of God Health Care is proud to be at the forefront of research that aims to better support patients, including following treatment for ovarian cancer through a new donor-funded clinical trial  called ‘Getting the MOST (Measure of Ovarian Symptoms and Treatment concerns) out of Ovarian Cancer Follow-Up’. Led by Professor Paul Cohen, the trial has the potential to change the way in which ovarian, fallopian tube and primary peritoneal cancer patients receive follow up care.

Director of the Ladybird Foundation Dr Pamela Hendry presents cheque to Professor Paul Cohen, Issy Black, and St John of God Foundation Philanthropy Manager Maria Moffitt.

Read More